--- title: R&D Tax Credits For the Pharmaceutical Sector description: Use an expert in pharmaceutical sector R&D tax credits to ensure your claim is quick and maximal. Check our credentials and start your claim today. --- [0208 062 6837](tel:02080626837) [info@queenslc.com](mailto:info@queenslc.com) [![QLC](https://queenslc.com/hs-fs/hubfs/Queenslc_July2024/images/QLCLogo.png?width=384&height=117&name=QLCLogo.png "QLC")](https://queenslc.com/home?hsLang=en) - [Our R&D Gateway](https://queenslc.com/rd-tax-credit-software-portal/) - [R&D Tax Credits](https://queenslc.com/rd-tax-credit-services/rd-tax-credit-claims/) - [Why choose QLC?](https://queenslc.com/why-choose-qlc/) - [HMRC Enquiries & Compliance](https://queenslc.com/enquiries) - [R&D Sectors](https://queenslc.com/sectors/) - [Small/SMEs](https://queenslc.com/sectors/rn-and-d-tax-credits-smes-small-business/) - [Large](https://queenslc.com/sectors/r-and-d-tax-credits-large-companies/) - [Startups](https://queenslc.com/sectors/startups-r-and-d-tax-credits/) - [Pharmaceutical](https://queenslc.com/sectors/pharmaceutical-r-and-d-tax-credits/) - [Technology](https://queenslc.com/sectors/architecture-r-and-d-tax-credits/-0) - [Manufacturing](https://queenslc.com/sectors/manufacturing-r-and-d-tax-credits/) - [Construction](https://queenslc.com/sectors/construction-r-and-d-tax-credits/) - [Software Development](https://queenslc.com/sectors/software-development-r-and-d-tax-credits/) - [Agriculture](https://queenslc.com/sectors/agriculture-r-and-d-tax-credits/) - [Fintech](https://queenslc.com/sectors/fintech-r-and-d-tax-credits/) - [Cloud Computing](https://queenslc.com/sectors/ai-robotics-r-and-d-tax-credits/-0) - [Engineering](https://queenslc.com/sectors/engineering-r-and-d-tax-credits/) - [AI & Robotics](https://queenslc.com/sectors/ai-robotics-r-and-d-tax-credits/) - [Food & Drink](https://queenslc.com/sectors/food-and-drink-r-and-d-tax-credits/) - [Medtech](https://queenslc.com/sectors/medtech-r-and-d-tax-credits/) - [Textiles](https://queenslc.com/sectors/textiles-sector-r-and-d-tax-credits/) - [R&D Success Stories](https://queenslc.com/r-and-d-tax-credit-examples/) - [Electrifying a Classic Porsche](https://queenslc.com/electrifying-a-porsche-an-rd-tax-credit-case-study) - [Machines Driving Efficiency](https://queenslc.com/moulding-engineering-r-and-d-case-study/) - [Engineering Stability](https://queenslc.com/cruise-ship-engineering-r-and-d-case-study/) - [Tools of the Trade](https://queenslc.com/tooling-engineering-r-and-d-case-study/) - [Pioneering Natural Weight-Loss Treatment](https://queenslc.com/weight-loss-r-and-d-case-study) - [Reviving A Maserati](https://queenslc.com/maserati-engineering-r-and-d-case-study/) - Resources - [R&D Accounting Support](https://queenslc.com/resources/accounting-for-r-and-d-tax-credit/) - [R&D Tax Calculator](https://queenslc.com/resources/r-and-d-tax-credit-calculator/) - [Enquiry Risk Calculator](https://queenslc.com/resources/enquiry-risk-calculator/) - [Insights](https://queenslc.com/blog) - [Check Your Claim Notification Deadline](https://queenslc.com/pnf-tool) - [HMRC R&D Pre-Notification Form](https://queenslc.com/resources/hmrc-rd-pre-notification-form) - [About Us](https://queenslc.com/about/) - [Contact Us](https://queenslc.com/about/contact/) - [Team](https://queenslc.com/about/team/) - [Work at QLC](https://queenslc.com/about/careers/) - [Referral Programme](https://queenslc.com/referrals/accountants) - [Partner](https://queenslc.com/referrals/partner) - [Accountants](https://queenslc.com/referrals/accountants) - [Clients](https://queenslc.com/referrals/client) - [Film & TV Tax Credits](https://queenslc.com/film-tax-relief) [Login | Sign Up](https://app.queenslc.co.uk/) [![QLC](https://queenslc.com/hs-fs/hubfs/raw_assets/public/Queenslc_July2024/images/header-logo.png?width=141&height=78&name=header-logo.png "QLC")](https://queenslc.com/home?hsLang=en) - [Our R&D Gateway](https://queenslc.com/rd-tax-credit-software-portal/) - [R&D Tax Credits](https://queenslc.com/rd-tax-credit-services/rd-tax-credit-claims/) - [Why choose QLC?](https://queenslc.com/why-choose-qlc/) - [HMRC Enquiries & Compliance](https://queenslc.com/enquiries) - [R&D Sectors](https://queenslc.com/sectors/) - [Small/SMEs](https://queenslc.com/sectors/rn-and-d-tax-credits-smes-small-business/) - [Large](https://queenslc.com/sectors/r-and-d-tax-credits-large-companies/) - [Startups](https://queenslc.com/sectors/startups-r-and-d-tax-credits/) - [Pharmaceutical](https://queenslc.com/sectors/pharmaceutical-r-and-d-tax-credits/) - [Technology](https://queenslc.com/sectors/architecture-r-and-d-tax-credits/-0) - [Manufacturing](https://queenslc.com/sectors/manufacturing-r-and-d-tax-credits/) - [Construction](https://queenslc.com/sectors/construction-r-and-d-tax-credits/) - [Software Development](https://queenslc.com/sectors/software-development-r-and-d-tax-credits/) - [Agriculture](https://queenslc.com/sectors/agriculture-r-and-d-tax-credits/) - [Fintech](https://queenslc.com/sectors/fintech-r-and-d-tax-credits/) - [Cloud Computing](https://queenslc.com/sectors/ai-robotics-r-and-d-tax-credits/-0) - [Engineering](https://queenslc.com/sectors/engineering-r-and-d-tax-credits/) - [AI & Robotics](https://queenslc.com/sectors/ai-robotics-r-and-d-tax-credits/) - [Food & Drink](https://queenslc.com/sectors/food-and-drink-r-and-d-tax-credits/) - [Medtech](https://queenslc.com/sectors/medtech-r-and-d-tax-credits/) - [Textiles](https://queenslc.com/sectors/textiles-sector-r-and-d-tax-credits/) - [R&D Success Stories](https://queenslc.com/r-and-d-tax-credit-examples/) - [Electrifying a Classic Porsche](https://queenslc.com/electrifying-a-porsche-an-rd-tax-credit-case-study) - [Machines Driving Efficiency](https://queenslc.com/moulding-engineering-r-and-d-case-study/) - [Engineering Stability](https://queenslc.com/cruise-ship-engineering-r-and-d-case-study/) - [Tools of the Trade](https://queenslc.com/tooling-engineering-r-and-d-case-study/) - [Pioneering Natural Weight-Loss Treatment](https://queenslc.com/weight-loss-r-and-d-case-study) - [Reviving A Maserati](https://queenslc.com/maserati-engineering-r-and-d-case-study/) - Resources - [R&D Accounting Support](https://queenslc.com/resources/accounting-for-r-and-d-tax-credit/) - [R&D Tax Calculator](https://queenslc.com/resources/r-and-d-tax-credit-calculator/) - [Enquiry Risk Calculator](https://queenslc.com/resources/enquiry-risk-calculator/) - [Insights](https://queenslc.com/blog) - [Check Your Claim Notification Deadline](https://queenslc.com/pnf-tool) - [HMRC R&D Pre-Notification Form](https://queenslc.com/resources/hmrc-rd-pre-notification-form) - [About Us](https://queenslc.com/about/) - [Contact Us](https://queenslc.com/about/contact/) - [Team](https://queenslc.com/about/team/) - [Work at QLC](https://queenslc.com/about/careers/) - [Referral Programme](https://queenslc.com/referrals/accountants) - [Partner](https://queenslc.com/referrals/partner) - [Accountants](https://queenslc.com/referrals/accountants) - [Clients](https://queenslc.com/referrals/client) - [Film & TV Tax Credits](https://queenslc.com/film-tax-relief) [Client Login](https://app.queenslc.co.uk/) # **R&D Tax Credits For The Pharmaceutical Sector** ##### **Get the sector experience you need to make a successful R&D tax relief claim** QLC helps pharmaceutical companies accelerate their R&D claims with our streamlined portal and expert team. ![pharmaceutical_sector_r_&_d_sector](https://queenslc.com/hs-fs/hubfs/pharmaceutical_sector_r_%26_d_sector.png?width=500&height=368&name=pharmaceutical_sector_r_%26_d_sector.png "pharmaceutical_sector_r_&_d_sector") [Try the Portal for Free](https://app.queenslc.co.uk/sign-up) [Speak to an expert](https://queenslc.com/about/contact/?hsLang=en) ![pharmaceutical_sector_experience_r_&_d_qlc 1](https://queenslc.com/hs-fs/hubfs/pharmaceutical_sector_experience_r_%26_d_qlc%201.png?width=450&height=300&name=pharmaceutical_sector_experience_r_%26_d_qlc%201.png "pharmaceutical_sector_experience_r_&_d_qlc 1") ## **Our pharmaceutical sector experience** With many years of experience helping pharmaceutical companies take advantage of R&D tax incentives, QLC understands the unique challenges and opportunities in your industry. We've helped many pharmaceutical businesses claim millions in R&D tax credits. Let QLC help you. Find out more in our pharmaceutical sector success stories below: # **Pharmaceutical R&D Tax Relief success stories** See how we help pharmaceutical companies leverage R&D tax relief to innovate, improve machinery performance, and reduce costs. ###### CASE study ## **Pioneering Natural Weight-Loss Treatment** QLC’s client set out to address a significant gap in the weight-loss treatment market. Existing products offered limited effectiveness, while surgical interventions, though impactful, were invasive, costly, and inaccessible for many patients. The client aimed to develop an affordable, natural weight-loss tablet that could safely modulate appetite by triggering the secretion of appetite-suppressing hormones in the large bowel. Achieving this goal required overcoming scientific uncertainties and conducting extensive research and development. ![case_study_natural_treatment_qlc_r_7_d 1](https://queenslc.com/hs-fs/hubfs/case_study_natural_treatment_qlc_r_7_d%201.png?width=682&height=453&name=case_study_natural_treatment_qlc_r_7_d%201.png "case_study_natural_treatment_qlc_r_7_d 1") ## Approach The client embarked on a comprehensive R&D journey to develop a treatment that was both effective and safe. Key stages of the project included: Early Research: - Using tissue assay platforms to evaluate combinations of natural substances. - Identifying formulations that could modulate hormone secretion effectively. Formulation Development: - Experimenting with the transition of the formulation from a paste to a powder to improve its usability and scalability. - Ensuring that the change in form did not compromise the treatment’s performance.  Clinical Trials: - Conducting trials to test the formulation's effectiveness in appetite suppression. - Exploring the impact of varying doses on hormone secretion to determine optimal dosages. By the end of the last claim period, the treatment was in its final stages of development. The client had successfully navigated key technical challenges, including identifying an effective natural formulation and optimising its delivery format. This innovative approach has the potential to transform weight-loss treatment, providing a safe and accessible alternative to surgical interventions. #### **The Process** QLC worked closely with the client to ensure that all eligible R&D activities were identified and claimed. The client’s qualifying activities included: - Investigating potential natural ingredient combinations. - Conducting tissue assays and other in vitro studies. - Managing the transition from paste to powder formulation. - Running clinical trials to evaluate effectiveness and dosing. #### Results The R&D tax credits claimed enabled the client to reinvest in their research, ensuring they could continue pushing the boundaries of innovation in weight-loss treatments. This project highlights the value of R&D in tackling global health challenges. By leveraging natural ingredients and rigorous scientific methods, the client is poised to make a meaningful impact on the weight-loss market. With QLC’s guidance, they unlocked vital funding to drive their innovation forward. ![hmrc_resized](https://queenslc.com/hs-fs/hubfs/Queenslc_July2024/images/hmrc_resized.png?width=300&height=270&name=hmrc_resized.png "hmrc_resized") ###### Success stories ## What Our Clients Say About Us "I am really impressed with the efficiency of your work, and the results you got for our company. A very friendly, committed and obviously hardworking team. You made the whole process very easy." ### Will Tompkins (Director) Vintage and Classic Cars "QLC successfully claimed credits for the past 2 financial years, this year was even better. They managed the application and claimed the R&D credit prior to our annual tax bill, making the whole process quicker, easier and more efficient than last year." ### Andrew Forbes (Director) Architecture "A massive thanks to all your team, obviously with the current situation, this money couldn’t have come at a better time." ### Ian Cooke (Director) Engineering "From our experience we have always found QLC to be efficient and thorough in their tax appraisals, carefully guiding us through the often complex process. They have a very approachable team, all of which have been able to offer excellent advice when needed." ### Ben Reed (Director) Architecture "They are proactive and efficient in performing their service and I have been impressed by their dynamism." ### Chris Wright (Director) Motorsport Engineering "Your company did exactly what you said it would do. It took far less time than the other company that we had used in the past. We are extremely pleased with the outcome." ### Adrian Smith (Company Sec) Manufacturing Firm "I am really impressed with the efficiency of your work, and the results you got for our company. A very friendly, committed and obviously hardworking team. You made the whole process very easy." ### Will Tompkins (Director) Vintage and Classic Cars "QLC successfully claimed credits for the past 2 financial years, this year was even better. They managed the application and claimed the R&D credit prior to our annual tax bill, making the whole process quicker, easier and more efficient than last year." ### Andrew Forbes (Director) Architecture "A massive thanks to all your team, obviously with the current situation, this money couldn’t have come at a better time." ### Ian Cooke (Director) Engineering "From our experience we have always found QLC to be efficient and thorough in their tax appraisals, carefully guiding us through the often complex process. They have a very approachable team, all of which have been able to offer excellent advice when needed." ### Ben Reed (Director) Architecture "They are proactive and efficient in performing their service and I have been impressed by their dynamism." ### Chris Wright (Director) Motorsport Engineering "Your company did exactly what you said it would do. It took far less time than the other company that we had used in the past. We are extremely pleased with the outcome." ### Adrian Smith (Company Sec) Manufacturing Firm ## How much could you claim? ### The average R&D tax claim in the pharmaceutical sector  For your own quick estimate, you can use our easy-to-use R&D tax calculator: [Get Your Estimate Now](https://queenslc.com/resources/r-and-d-tax-credit-calculator/?hsLang=en) # £ 50 k ![qlc_r_&_d_drug_development](https://queenslc.com/hs-fs/hubfs/qlc_r_%26_d_drug_development.png?width=500&height=333&name=qlc_r_%26_d_drug_development.png "qlc_r_&_d_drug_development") # Drug discovery and development ### Early-stage discovery research Identifying new drug candidates through chemical synthesis, biological screening, or computational modelling. ### Target validation Confirming the biological relevance of a drug target and its role in a disease process. ### Biomarker identification Discovering and validating biomarkers that may predict response to treatment or indicate disease progression. ### Development of high-throughput screening (HTS) assays Creating and validating assays to rapidly test thousands of compounds for biological activity. ### Lead identification and optimization Developing chemical compounds or biological entities (e.g., antibodies, proteins) with potential therapeutic effects and optimising them for efficacy, selectivity, and safety. ### Structure-activity relationship (SAR) studies Understanding how molecular changes impact biological activity to optimise drug candidates. ### Hit-to-lead and lead-to-candidate processes Refining compounds identified in screening assays to generate viable drug candidates. # **Preclinical studies** ![r_&_D_preclinical_studies](https://queenslc.com/hs-fs/hubfs/r_%26_D_preclinical_studies.png?width=350&height=350&name=r_%26_D_preclinical_studies.png "r_&_D_preclinical_studies") ### In vitro studies Laboratory-based studies to test drug effects on cells or biochemical pathways. ### Toxicology studies Researching the potential adverse effects of drug candidates and their safety profiles. ### In vivo studies Testing drugs in animal models to assess efficacy, toxicity, and pharmacokinetics. ### Pharmacokinetic (PK) and pharmacodynamic (PD) studies: Investigating how a drug is absorbed, distributed, metabolised, and excreted in the body and how it interacts with its biological target. ### Formulation development Creating the drug in a form that can be administered to patients (e.g., tablet, injection, inhaler) and ensuring stability and bioavailability. ![qlc_r_&_d_clinical_trials](https://queenslc.com/hs-fs/hubfs/qlc_r_%26_d_clinical_trials.png?width=350&height=350&name=qlc_r_%26_d_clinical_trials.png "qlc_r_&_d_clinical_trials") # **Clinical trials (phases I-III)** ### Phase I clinical trials Testing new drug candidates in humans for the first time to assess safety, dosage, and side effects. ### Phase II clinical trials Evaluating efficacy and side effects in a larger patient population to determine optimal dosing and therapeutic effects. ### Phase III clinical trials Large-scale studies to confirm efficacy, monitor side effects, and compare the new drug to existing treatments. ### Clinical trial design and protocol development Designing trials to meet regulatory requirements and ensure scientifically sound results. ### Clinical data collection and analysis Gathering and analysing data from clinical trials, including efficacy and safety outcomes. ### Adaptive trial designs Implementing flexible trial designs that allow for modifications based on interim results, which can improve efficiency and reduce costs. # **Regulatory and compliance activities** ![Regulatory_and_compliance_activities_qlc_r_&_d](https://queenslc.com/hs-fs/hubfs/Regulatory_and_compliance_activities_qlc_r_%26_d.png?width=500&name=Regulatory_and_compliance_activities_qlc_r_%26_d.png "Regulatory_and_compliance_activities_qlc_r_&_d") ### Good Manufacturing Practice (GMP) development Developing and validating processes to ensure drugs are consistently produced to high-quality standards. ### New process validation Creating, refining, and validating manufacturing processes for novel therapies, including biologics or gene therapies. ### Regulatory science Research to develop new methods and tools for assessing drug safety and efficacy, supporting regulatory submissions. ### Regulatory submission preparation Preparing scientific and technical documentation for regulatory approval. ![biotechnology_R&D_qlc_r_&_D](https://queenslc.com/hs-fs/hubfs/biotechnology_R%26D_qlc_r_%26_D.png?width=500&name=biotechnology_R%26D_qlc_r_%26_D.png "biotechnology_R&D_qlc_r_&_D") # **Biopharmaceutical and biotechnology R&D** ### Biologics development Researching and developing complex biological products such as monoclonal antibodies, vaccines, or cell therapies. ### Process scale-up for biologics Scaling up the manufacturing processes for biologics from laboratory scale to commercial production. ### Biosimilar development Developing biologics that are similar to existing approved biologics, focusing on demonstrating biosimilarity in terms of efficacy, safety, and quality. ### Gene and cell therapy development Engineering viral vectors or modifying cells to create new gene or cell-based therapies. ### Protein engineering and optimization Developing new techniques to enhance the stability, activity, or delivery of therapeutic proteins. ### Advanced delivery mechanisms Creating novel drug delivery systems, such as nanoparticles, liposomes, or sustained-release formulations. # **Advanced technologies and automation** ![advanced_tech_qlc_r_&_d](https://queenslc.com/hs-fs/hubfs/advanced_tech_qlc_r_%26_d.png?width=350&name=advanced_tech_qlc_r_%26_d.png "advanced_tech_qlc_r_&_d") ### Artificial Intelligence (AI) and machine learning (ML) in drug discovery Using AI and ML to identify drug targets, predict drug behaviour, and optimise drug development. ### Computational modelling and simulations Applying in silico techniques to predict drug interactions, optimise trial design, or reduce the need for animal testing. ### Digital health and remote monitoring tools Creating technologies to collect real-time patient data during clinical trials or after a drug is marketed to enhance patient monitoring and compliance. ### Personalised medicine Developing tailored treatments based on genetic, environmental, or lifestyle factors. ### Automation of laboratory processes Implementing robotics and high-throughput automation to improve the efficiency of drug discovery, formulation, or testing processes. # **Manufacturing and process development** ![manufacture_qlc_r_&_d](https://queenslc.com/hs-fs/hubfs/manufacture_qlc_r_%26_d.png?width=500&name=manufacture_qlc_r_%26_d.png "manufacture_qlc_r_&_d") ### Process innovation and scale-up Developing innovative manufacturing techniques to increase yield, reduce costs, or improve the quality of drug products. ### Continuous manufacturing processes Researching and implementing continuous production methods to improve efficiency and reduce batch variability. ### Bioprocess optimization Enhancing the efficiency of cell culture, fermentation, or downstream purification processes for biologics manufacturing. ### Nanotechnology Using nanotechnology to create more effective drug delivery systems or to develop novel therapeutic approaches. ![post_market_qlc_stidies_](https://queenslc.com/hs-fs/hubfs/post_market_qlc_stidies_.png?width=500&name=post_market_qlc_stidies_.png "post_market_qlc_stidies_") # **Post-market R&D and phase IV studies** ### Post-marketing surveillance studies Collecting and analysing data on the long-term effects of drugs once they are available on the market. ### Pharmacovigilance research Identifying, evaluating, and mitigating drug-related adverse events to ensure patient safety. ### Real-world evidence studies Conducting observational studies using real-world data to evaluate drug performance in routine clinical practice. # **Cross-disciplinary and collaborative research** ![collaborative_research_r_&_d](https://queenslc.com/hs-fs/hubfs/collaborative_research_r_%26_d.png?width=500&name=collaborative_research_r_%26_d.png "collaborative_research_r_&_d") ### Collaborative R&D Working with universities, research institutions, or other pharmaceutical companies to share knowledge, tools, or facilities to advance drug discovery and development. ### Public-private partnerships Engaging in partnerships with governmental bodies or public health organisations to advance research on neglected diseases, rare diseases, or pandemic preparedness. ### Open-source research initiatives Participating in open-source platforms or databases to share data and accelerate the discovery of new therapies. ![rare_pharma_development_qlc_r_&_d](https://queenslc.com/hs-fs/hubfs/rare_pharma_development_qlc_r_%26_d.png?width=350&name=rare_pharma_development_qlc_r_%26_d.png "rare_pharma_development_qlc_r_&_d") # **Rare and orphan drug development** ### Orphan drug research Developing treatments for rare diseases, where there is often limited market incentive but significant unmet medical need. ### Paediatric formulation development Tailoring drug formulations specifically for children, ensuring suitable dosage forms, taste, and safety. ###### Why choose QLC? ## QLC and our portal help businesses like yours claim R&D tax credits and tax relief faster and more successfully than ever. ##### End-to-end service ##### Easy-to-use customer portal ##### Faster payouts than our competitors ##### See your money in 16 days ##### Flexible comms ##### All sectors and sizes ##### No minimum fee ##### Stakeholder transparency ###### [More reasons to choose QLC](https://queenslc.com/why-choose-qlc?hsLang=en) #### What qualifies as R&D in the pharmaceutical sector for tax credit purposes? Qualifying R&D activities in the pharmaceutical sector typically include anything that seeks to resolve scientific or technological uncertainties, such as drug discovery, clinical trials, formulation development, and scaling up manufacturing processes. See above for a complete list. #### Are clinical trials eligible for R&D tax relief? Yes, clinical trials, including Phases I, II, and III, are typically eligible for R&D tax relief. The activities must aim to resolve scientific or technological uncertainty, such as understanding drug efficacy, safety, dosage, or side effects. #### Can failed projects still qualify for R&D tax credits? Yes, unsuccessful or failed R&D projects can still qualify, as the goal is to resolve uncertainties, even if the project doesn’t achieve the desired outcome. The key is that you are advancing scientific knowledge or capabilities in the process. #### Are regulatory compliance activities eligible for R&D tax relief? Not all regulatory activities qualify for R&D tax relief. However, activities that support regulatory compliance and involve scientific or technological uncertainties, such as developing new manufacturing processes that meet Good Manufacturing Practice (GMP) standards or preparing scientific data for regulatory submissions, can be eligible. #### What costs can be included in an R&D tax relief claim? Eligible costs include staff salaries, materials used in R&D activities, software, utilities, and subcontractor costs related to R&D. In clinical trials, the cost of patient recruitment, trial design, and data analysis may also be included. #### How do subcontractor costs work in the pharmaceutical sector? If you subcontract R&D work to a third party (e.g., a Contract Research Organisation (CRO)), the costs may still qualify for R&D tax relief, although the amount you can claim depends on whether you are an SME or a large company and how the subcontractor is engaged. #### How are R&D tax credits affected by government grants and funding in the pharmaceutical sector? Receiving government grants or state aid can affect your eligibility for the SME R&D tax relief scheme. In such cases, the project may need to be claimed under the RDEC scheme, which offers a lower benefit rate. #### Can I claim for both internal R&D and externally contracted research? Yes, you can claim for both in-house R&D activities and externally contracted R&D, provided they are part of qualifying R&D projects. Subcontractor costs can be claimed, but the percentage of costs that are eligible depends on the scheme you are using (SME or RDEC). #### How far back can I claim R&D tax credits? You can make a claim for R&D tax relief for up to two financial years after the end of the accounting period in which the R&D expenditure occurred. #### What records or documentation do I need to support my R&D tax credit claim? To support your R&D tax credit claim, it’s essential to keep documentation that describes the technical challenges you’re addressing and the activities involved in overcoming them. Detailed project reports aren’t strictly necessary; as long as you can provide a clear explanation of your R&D efforts, we can assist with defining eligible costs. Time sheets aren’t always required, but having records that outline who was involved and approximate time allocations can be helpful. Our team will guide you to ensure that all relevant information is captured for a successful claim. #### How does R&D tax credit work for partnerships between pharmaceutical companies and universities? If a pharmaceutical company collaborates with a university, it may still claim R&D tax credits for its share of the qualifying R&D work. The nature of the agreement and whether the company bears the financial risk of the project will affect the claim's eligibility. #### How are R&D tax credits calculated for pharmaceutical companies with global operations? For UK R&D tax relief, only R&D activities and associated costs incurred within the UK are eligible. However, costs associated with overseas subcontractors or clinical trials conducted abroad may still qualify, depending on the nature of the work and the tax credit scheme being used. #### Can software development related to pharmaceutical R&D be claimed? Yes, as long as this work involves the resolution of technological uncertainty. Software development specifically related to R&D, such as the creation of tools for data analysis, drug discovery, or process automation, can be claimed under R&D tax relief. #### Can we claim R&D tax credits for improving existing drugs or treatments? If improvements to an existing drug or treatment involve significant scientific or technological challenges - such as increasing efficacy, reducing side effects, or enhancing drug delivery - those activities can qualify for R&D tax credits. #### How does Brexit impact R&D tax credits in the pharmaceutical sector? Brexit itself does not directly impact R&D tax credits in the UK, as they are governed by UK law. However, changes to funding programs or regulatory frameworks as a result of Brexit may affect individual companies’ activities or eligibility. #### What is the process for claiming R&D tax credits in the pharmaceutical sector? The process for claiming R&D tax credits in the pharmaceutical sector involves first identifying eligible projects. Our team will help gather the necessary cost data, prepare the technical report, and handle the entire submission process. We take care of writing and submitting the report, amending your corporation tax return as needed, and ensuring that all relevant costs are accurately captured for the claim. ![qlc_r&d_more_about_portal](https://queenslc.com/hubfs/qlc_r%26d_more_about_portal.jpg) Many pharmaceutical companies work with specialist advisors like us to ensure they maximise their claims and comply with HMRC’s requirements. Why not get in touch or start a trial of our R&D tax claim portal? [Talk to an expert](https://queenslc.com/about/contact/?hsLang=en) [![Queens](https://queenslc.com/hs-fs/hubfs/Queenslc_July2024/images/QLCLogoWhite2.png?width=268&name=QLCLogoWhite2.png "Queens")](https://queenslc.com/oldhome?hsLang=en) ### Find us 4 Manchester Square London W1U 3PD United Kingdom ### Contact Us info@queenslc.com Monday to Friday, 08:30 to 17:00 0208 062 6837 © 2024 Queen’s Lane Consultants Limited. Company Number 11450705. VAT Number 300 9457 25. ✕